Importance:
Although numerous studies have shown an association between alcohol consumption and cancer, how changes in drinking behavior increase or decrease the incidence of cancer is not well understood.
Objective:
To investigate the association between the reduction, cessation, or increase of alcohol consumption and the development of alcohol-related cancers and all cancers.
Design, Setting, And Participants:
This population-based cohort study analyzed adult beneficiaries in the Korean National Health Insurance Service. Participants (aged ≥40 years) included those who underwent a national health screening in both 2009 and 2011 and had available data on their drinking status. Data were analyzed from April 16 to July 6, 2020.
Exposures:
Alcohol consumption level, which was self-reported by participants in health screening questionnaires, was categorized into none (0 g/d), mild (<15 g/d), moderate (15-29.9 g/d), and heavy (≥30 g/d) drinking. Based on changes in alcohol consumption level from 2009 to 2011, participants were categorized into the following groups: nondrinker, sustainer, increaser, quitter, and reducer.
Main Outcomes And Measures:
The primary outcome was newly diagnosed alcohol-related cancers (including cancers of the head and neck, esophagus, colorectum, liver, larynx, and female breast), and the secondary outcome was all newly diagnosed cancers (except for thyroid cancer).
Results:
Among the 4 513 746 participants (mean [SD] age, 53.6 [9.6] years; 2 324 172 [51.5%] men), the incidence rate of cancer was 7.7 per 1000 person-years during a median (IQR) follow-up of 6.4 (6.1-6.6) years. Compared with the sustainer groups at each drinking level, the increaser groups had a higher risk of alcohol-related cancers and all cancers. The increased alcohol-related cancer incidence was associated with dose; those who changed from nondrinking to mild (adjusted hazard ratio [aHR], 1.03; 95% CI, 1.00-1.06), moderate (aHR, 1.10; 95% CI, 1.02-1.18), or heavy (aHR, 1.34; 95% CI, 1.23-1.45) drinking levels had an associated higher risk than those who did not drink. Those with mild drinking levels who quit drinking had a lower risk of alcohol-related cancer (aHR, 0.96; 95% CI, 0.92-0.99) than those who sustained their drinking levels. Those with moderate (aHR, 1.07; 95% CI, 1.03-1.12) or heavy (aHR, 1.07; 95% CI, 1.02-1.12) drinking levels who quit drinking had a higher all cancer incidence than those who sustained their levels, but when quitting was sustained, this increase in risk disappeared. Compared with sustained heavy drinking, reduced heavy drinking levels to moderate levels (alcohol-related cancer: aHR, 0.91 [95% CI, 0.86-0.97]; all cancers: aHR, 0.96 [95% CI, 0.92-0.99]) or mild levels (alcohol-related cancer: aHR, 0.92 [95% CI, 0.86-0.98]; all cancers: aHR, 0.92 [95% CI, 0.89-0.96]) were associated with decreased cancer risk.
Conclusions And Relevance:
Results of this study showed that increased alcohol consumption was associated with higher risks for alcohol-related and all cancers, whereas sustained quitting and reduced drinking were associated with lower risks of alcohol-related and all cancers. Alcohol cessation and reduction should be reinforced for the prevention of cancer.
Citing Articles
Diabetes Mellitus and Hyperlipidemia Status Among Hypertensive Patients in the Community and Influencing Factors Analysis of Blood Pressure Control.
Zhang S, Yang Y, Chen X, Fan L, Wu J, Liu X
J Clin Hypertens (Greenwich). 2025; 27(2):e14965.
PMID: 39999366
PMC: 11856054.
DOI: 10.1111/jch.14965.
Cumulative Burden of Lifestyle Risk Factors on Cancer in Older Korean Men: A Nationwide Retrospective Cohort Study.
Choi H, Kim S, Kim Y, Kim Y, Kim J, Sung M
Cancers (Basel). 2025; 17(3).
PMID: 39941795
PMC: 11815911.
DOI: 10.3390/cancers17030426.
Effect of alcohol consumption on oncological treatment effectiveness and toxicity in patients with cancer: a systematic review and meta-analysis.
Fountoukidis G, Schiza A, Smith D, Othman M, Bergman M, Ahlgren J
BMC Cancer. 2025; 25(1):246.
PMID: 39939877
PMC: 11823036.
DOI: 10.1186/s12885-025-13694-z.
Changes in drinking levels and metabolic dysfunction-associated steatotic liver disease: a longitudinal study from the China multi-ethnic cohort study.
Zhang N, Li J, Xie X, Hu Y, Chen H, Zhang Y
BMC Public Health. 2025; 25(1):556.
PMID: 39934719
PMC: 11817541.
DOI: 10.1186/s12889-025-21752-1.
The impact of weight change on suicide mortality: a nationwide population-based cohort study of 2 million Koreans.
Kim K, Jung J, Um Y, Ahn Y, Ko S, Han K
Diabetol Metab Syndr. 2025; 17(1):20.
PMID: 39828720
PMC: 11743014.
DOI: 10.1186/s13098-024-01559-7.
Understanding Fatigue, Insomnia, and COVID-19 PTSS Among Mainland Chinese During Initial Post-Zero-COVID Infection Wave: A Multi-Group Analysis.
Wang S, Xu Y, Julich S, Weng L, Jin Q, Wei Y
Behav Sci (Basel). 2024; 14(11).
PMID: 39594333
PMC: 11590877.
DOI: 10.3390/bs14111033.
Unhealthy alcohol use: screening and behavioral counseling interventions.
Jung W, Oh S, Kim S, Kim S
Korean J Fam Med. 2024; 46(1):20-26.
PMID: 39529457
PMC: 11824420.
DOI: 10.4082/kjfm.24.0115.
Effect of chronic alcohol consumption on oral microbiota in rats with periodontitis.
Zhao Z, Zhang X, Zhao W, Wang J, Peng Y, Liu X
PeerJ. 2024; 12:e17795.
PMID: 39148678
PMC: 11326440.
DOI: 10.7717/peerj.17795.
Risk of esophageal cancer in liver transplant recipients: systematic review and meta-analysis.
Li S, Zhang S, Sun X
J Gastrointest Oncol. 2024; 15(3):851-861.
PMID: 38989401
PMC: 11231872.
DOI: 10.21037/jgo-24-66.
[Hypothetical Alcohol Consumption Interventions and Hepatic Steatosis: A Longitudinal Study in a Large Cohort].
Zhang N, Zhang Y, Wei J, Xiang Y, Hu Y, Xiao X
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024; 55(3):653-661.
PMID: 38948274
PMC: 11211800.
DOI: 10.12182/20240560503.
Gut-liver highway of ALDH2 in drinking.
Pandey S, Malovic E
Nat Metab. 2024; 6(7):1202-1203.
PMID: 38902330
DOI: 10.1038/s42255-024-01071-2.
Feasibility and Acceptability Evaluation of a Digital Therapeutic Program for Improving Cancer Prevention: A Quasi-experimental Pre-post Interventional Pilot Study.
Zhang X, Zhang S, Zhang H, Xiong Z, Li Y, Li L
J Cancer Educ. 2024; 39(5):520-529.
PMID: 38898222
DOI: 10.1007/s13187-024-02431-y.
Greater physical activity levels are associated with lower prevalence of tumors and risk of cancer in Spanish population: A cross-sectional study.
Franco-Garcia J, Castillo-Paredes A, Rodriguez-Redondo Y, Carlos-Vivas J, Garcia-Carrillo R, Denche-Zamorano A
Heliyon. 2024; 10(7):e29191.
PMID: 38623236
PMC: 11016703.
DOI: 10.1016/j.heliyon.2024.e29191.
Cardiovascular disease and cancer: shared risk factors and mechanisms.
Wilcox N, Amit U, Reibel J, Berlin E, Howell K, Ky B
Nat Rev Cardiol. 2024; 21(9):617-631.
PMID: 38600368
PMC: 11324377.
DOI: 10.1038/s41569-024-01017-x.
High Fischer Ratio Oligopeptides of Gluten Alleviate Alcohol-Induced Liver Damage by Regulating Lipid Metabolism and Oxidative Stress in Rats.
Zhao P, Hou Y, Chen X, Zhang M, Hu Z, Chen L
Foods. 2024; 13(3).
PMID: 38338571
PMC: 10855637.
DOI: 10.3390/foods13030436.
Inter- and transgenerational heritability of preconception chronic stress or alcohol exposure: Translational outcomes in brain and behavior.
Rice R, Gil D, Baratta A, Frawley R, Hill S, Farris S
Neurobiol Stress. 2024; 29:100603.
PMID: 38234394
PMC: 10792982.
DOI: 10.1016/j.ynstr.2023.100603.
Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases.
Ghanem P, Murray J, Marrone K, Scott S, Feliciano J, Lam V
RMD Open. 2023; 9(4).
PMID: 37914179
PMC: 10619011.
DOI: 10.1136/rmdopen-2023-003471.
Combinations of lifestyle behaviors and cancer risk among Korean adults.
Luu N, Bui T, Tran T, Nguyen T, Oh J
Sci Rep. 2023; 13(1):13765.
PMID: 37612448
PMC: 10447503.
DOI: 10.1038/s41598-023-40819-w.
Association of triglyceride/high-density lipoprotein cholesterol ratio with severe complications of COVID-19.
Chang Y, Jeon J, Song T, Kim J
Heliyon. 2023; 9(6):e17428.
PMID: 37366523
PMC: 10275776.
DOI: 10.1016/j.heliyon.2023.e17428.
NIAAA-Supported Research and the Public Discourse Around Alcohol: A Clarification Regarding Mitchell and McCambridge (2023).
Koob G
J Stud Alcohol Drugs. 2023; 84(2):346-347.
PMID: 37132578
PMC: 10171253.
DOI: 10.15288/jsad.23-00073.